Back to Search
Start Over
Reporting of R&D costs under IAS 38 - the case of biopharmaceutical companies
- Publication Year :
- 2022
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........fdee9d264a0a2d91fbf577ed66b1235d
- Full Text :
- https://doi.org/10.13140/rg.2.2.24934.09285